3.6. Chapter Summary

Today's lesson is focused on gene therapy, which we define as the introduction of genetic material into a patient to treat or prevent disease. Can anyone tell me why gene therapy is such an important aspect of modern medicine?

It helps fix genetic disorders or replace missing genes that cause diseases!

Exactly! Now, we have two main types of gene therapy: somatic and germline. Somatic gene therapy only affects the treated individual, while germline therapy can alter genes in egg or sperm cells. Let's remember this with the acronym SAGE: Somatic and Germline Effects.

What's the difference in acceptance between the two?

Good question! Somatic therapy is widely accepted, while germline therapy is often controversial due to ethical concerns. Can anyone think of an example of somatic gene therapy?

Isn't Luxturna for Leber’s Congenital Amaurosis a case of somatic therapy?

Right! Well done. Let's summarize: Gene therapy can target a specific genetic defect in somatic cells without affecting future generations. Remember SAGE as a mnemonic for somatic and germline therapies.

In this session, we’ll cover gene delivery systems. Does anyone know the methods we use to deliver genes into cells?

Viral vectors and non-viral methods!

Correct! Viral vectors, like AAV and lentiviruses, allow for long-term gene expression, while non-viral methods, like liposomes and electroporation, generally provoke a lower immune response. Let’s use the mnemonic VINE to remember: Viral and Invasive Non-viral Expressing systems.

How do we choose which method to use in therapy?

Great question! The choice depends on disease type, required duration of expression, and safety. For instance, CAR-T therapy utilizes modified T-cells that are reinfused into the patient. Let's summarize: The delivery method is crucial in its effectiveness, and VINE helps us remember the two categories.

Let's discuss clinical applications. Can anyone cite a disease treated using gene therapy?

Yes, Luxturna treats Leber’s Congenital Amaurosis by restoring vision.

Exactly! Luxturna is an excellent example of successful gene therapy. Also, Zolgensma for Spinal Muscular Atrophy delivers the SMN1 gene. Remember LZ: Luxturna for vision and Zolgensma for muscles.

What about therapies for cancer?

For cancer, we use CAR-T therapy, which engineered T-cells to target cancer cells. So, summarizing, gene therapy has real-world applications, and remember LZ to recall vision and muscle therapies.

We must also address the ethical aspects of gene therapy. Why do you think informed consent is crucial?

Patients need to understand the risks and benefits of the treatment.

Great point! Informed consent ensures patients are aware of what they are undergoing. Additionally, germline editing is banned in various countries due to ethical concerns. Let’s remember IRE: Informed consent, Regulation, Ethics.

What about the regulatory bodies involved?

Regulatory bodies like the FDA in the USA, EMA in Europe, and ICMR in India. They oversee the safety of gene therapies. So, remember IRE for the essentials of ethical considerations in gene therapy.

Let’s discuss emerging trends in gene therapy. Can anyone name a new technology being researched?

CRISPR! It's being used in clinical trials.

Absolutely! CRISPR is revolutionary for gene editing and is being trialed for conditions like Sickle Cell Disease and Beta-Thalassemia. Let's remember CGE: CRISPR, Gene Editing.

What about personalized therapies?

Personalized gene therapies based on genome sequencing are paving the way for tailored treatments. Summarizing: Emerging trends like CGE highlight the future possibilities in gene therapy.